VIGL: Vigil Neuroscience Inc. Narxning sof foyda o‘sishiga nisbati
Geopolitik keskinliklar ilmiy almashinuv va reagentlar logistikasini cheklab, dori vositalari sertifikatsiyasi uchun xavflarni keltirib chiqarmoqda. Biroq, mikrogliya aktivatsiyasi bo'yicha patentlar va qarzsiz balans hisoboti Vigil Neuroscience (VIGL) kompaniyasining mavqeini mustahkamlaydi, biomateriallarni yo'q qilish bo'yicha FDA standartlariga qat'iy rioya qilish esa ekologik xavflarni minimallashtiradi. Kompaniyaning joriy PEG baholashi narx dinamikasini namoyish etmoqda, bunda ko'rsatkich 0.00 atrofida saqlanmoqda.
Vigil Neuroscience (VIGL) kompaniyasi koʻrsatkichlari kesimi va tahlili
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi haqida ma'lumot:
- balans kapitallashuvi bo'yicha ma'lumotlar:
- qarz majburiyatlari va likvidlik statistikasi:
Barcha qarzlarning o‘z mablag‘lariga nisbati Vigil Neuroscience|VIGL - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati ko'rsatkichi vigilneuro.com|VIGL - Kompaniyaning jamlangan qarzlari|Balans qiymatiga qarzlar Vigil Neuro|VIGL - Kompaniyaning uzoq muddatli majburiyatlari|Kompaniyaning qisqa muddatli qarzlari Vigil Neuroscience|Oraliq qoplash koeffitsiyenti vigilneuro.com
- sof foyda va baholash koeffitsiyentlari ma'lumotlari:
VIGL - Kompaniyaning sof foydasi|Kutilayotgan sof foyda Vigil Neuroscience|VIGL - Narxning foydaga nisbati|Kapitalizatsiyaning prognoz qilingan foydaga nisbati vigilneuro.com|VIGL - PEG multiplikatori|Korxona qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati koeffitsiyenti Vigil Neuro|VIGL - EBITDA operatsion foydasi|So'nggi to'rtta chorak uchun bir aksiya uchun sof foyda Vigil Neuroscience|VIGL - Bir aksiya uchun sof foyda (EPS TTM)|So'nggi o'n ikki oy davomida yillik hisobda bir aksiya uchun foyda o'sishi vigilneuro.com|VIGL - Joriy yilda bir aksiya uchun foyda o'sishi|Keyingi yil uchun bir aksiya uchun foydaning prognoz qilingan o'sish sur'ati Vigil Neuroscience
Kompaniyaning umumiy tahlili:VIGL - Vigil Neuroscience Inc.
Vigil Neuroscience (VIGL) uchun xavfsizlik zaxirasini baholash narx-foyda koeffitsiyentining o'sish sur'atiga nisbatiga asoslangan bo'lib, bunda birdan past qiymat aktivning fundamental jihatdan qadrsizlanganligidan dalolat beradi. PEG koeffitsiyentini tahlil qilish orqali investor miya immunitetini tiklash uchun neyrodegenerativ kasalliklar va Altsgeymerga qarshi innovatsion terapiyalarni ishlab chiquvchi ushbu biotexnologiya ekspertining kengayish sur'atlarining kapitalizatsiya samaradorligini aniqlaydi.
Vigil Neuroscience kimlar bilan raqobatlashadi
O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Biogen Inc|PEG multiplikatori NBIX (Neurocrine Biosciences Inc)|Narxning sof foyda o‘sishiga nisbati Regencell Corp|Axsome Therapeutics - PEG multiplikatori|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati acadia-pharm.com ACAD|Xenon (XENE) - Narxning foydaga va o‘sish sur’atiga nisbati|VKTX (Viking Therapeutics Inc) - Narxning foydaga va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori SUPN|CPRX: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Denali Therapeutics (DNLI)|harmonybiosciences.com - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|PEG multiplikatori BHVN (Biohaven)|Amylyx Pharmaceuticals Inc (AMLX) - O‘sish sur’atiga tuzatilgan narx-foyda|TRVI: Narx-foyda va o‘sish multiplikatori|PRAX - PEG multiplikatori|Anavex Life Sciences (AVXL) - Narxning foydaga va o‘sish sur’atiga nisbati|ceribell.com - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Prothena Corporation plc|O‘sish sur’atiga tuzatilgan narx-foyda Alector Therapeutics ALEC|Narxning foydaga va o‘sish sur’atiga nisbati Annexon Inc. (ANNX)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati omeros.com|PEG multiplikatori NGNE (Neurogene Inc.)|ACIU - Narx-foyda va o‘sish multiplikatori|Voyager Therapeutics, Inc. - PEG multiplikatori|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Neumora NMRA|SCLX: PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Tevogen Bio Inc. (TVGN)|Narxning foydaga va o‘sish sur’atiga nisbati Alpha Cognition Inc|O‘sishni hisobga olgan narx-foyda koeffitsiyenti CGTX (cogrx.com)|PEG multiplikatori IKT|Narx-foyda va o‘sish multiplikatori Cassava Sciences Inc SAVA|PEG multiplikatori ASRT (Assertio)|Coya Therapeutics Inc (COYA) - O‘sish sur’atiga tuzatilgan narx-foyda|VTGN: Narx-foyda va o‘sish multiplikatori|OVID: Narxning foydaga va o‘sish sur’atiga nisbati|ABOS: PEG multiplikatori|CRVO - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|ATHE (Alterity Therapeutics Ltd.) - PEG multiplikatori|CLNN - Narxning sof foyda o‘sishiga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati PepGen Inc. (PEPG)|Narxning foydaga va o‘sish sur’atiga nisbati JUNS (jupiterneurosciences.com)|Narxning foydaga va o‘sish sur’atiga nisbati Relmada Therapeutics, Inc. RLMD|ANVS: O‘sishni hisobga olgan narx-foyda koeffitsiyenti|Grace Tx - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Firefly Neuro|KLTO (anewmeds.com) - Narx-foyda va o‘sish multiplikatori|NeuroSense Therapeutics Ltd. (NRSN) - PEG multiplikatori|Narxning foydaga va o‘sish sur’atiga nisbati Reviva Pharmaceuticals Holdings, Inc.|MTVA: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati NeurAxis, Inc (NRXS)|HSDT - O‘sish sur’atiga tuzatilgan narx-foyda|Passage Bio - Narx-foyda va o‘sish multiplikatori|Neuphoria Therapeutics, Inc. - Narxning foydaga va o‘sish sur’atiga nisbati|Minerva Neurosciences, Inc. - PEG multiplikatori|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Athira Pharma Inc ATHA|ADXN: PEG multiplikatori|Narxning sof foyda o‘sishiga nisbati Alzamend Neuro ALZN|CYCN (Cyclerion Therapeutics Inc.) - PEG multiplikatori|Protagenic (PTIX) - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati Pasithea Therapeutics (KTTA)|Narxning foydaga va o‘sish sur’atiga nisbati CRGT (cortigent.com)|Avenue Therapeutics, Inc - Narx-foyda va o‘sish multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti BCLI|CARA - Narxning foydaga va o‘sish sur’atiga nisbati|CHRO (chromocell.com) - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|ELYM: PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Intra-Cellular Therapies, Inc. (ITCI)|Narx-foyda va o‘sish multiplikatori LBPH|PEG multiplikatori Marinus Pharma|Narxning foydaga va o‘sish sur’atiga nisbati NKGen Biotech, Inc. (NKGN)|NRBO (neurobopharma.com) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Sage Therapeutics SAGE|Synaptogenix Inc. (SNPX) - O‘sish sur’atiga tuzatilgan narx-foyda|TRVN - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Anew Medical Inc. WENA|CERE: PEG multiplikatori
